Preoperative low hematocrit is an adverse prognostic biomarker in ovarian cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preoperative low hematocrit is an adverse prognostic biomarker in ovarian cancer
Authors
Keywords
-
Journal
ARCHIVES OF GYNECOLOGY AND OBSTETRICS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-10-04
DOI
10.1007/s00404-020-05822-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pre-diagnosis body mass index, physical activity and ovarian cancer mortality
- (2019) Abigail S. Zamorano et al. GYNECOLOGIC ONCOLOGY
- Ovarian cancer statistics, 2018
- (2018) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A turning point in the fight against ovarian cancer?
- (2018) Giovanni Scambia et al. LANCET ONCOLOGY
- Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteins
- (2018) Kalpana Deepa Priya Dorayappan et al. ONCOGENE
- Prognostic factors in epithelial ovarian cancer: A population-based study
- (2018) Lin-Chau Chang et al. PLoS One
- Dysregulation of iron metabolism in cancer stem cells
- (2018) Stefania Recalcati et al. FREE RADICAL BIOLOGY AND MEDICINE
- Association of pretreatment thrombocytosis with prognosis in ovarian cancer: a systematic review and meta-analysis
- (2018) Qingjian Ye et al. Journal of Gynecologic Oncology
- Long-term mortality among women with epithelial ovarian cancer: a population-based study in British Columbia, Canada
- (2018) Nimisha Arora et al. BMC CANCER
- Impact of diabetes mellitus on epithelial ovarian cancer survival
- (2018) Setareh Akhavan et al. BMC CANCER
- Systemic immune-inflammation index predicts prognosis in patients with epithelial ovarian cancer: A retrospective study
- (2018) Dan Nie et al. GYNECOLOGIC ONCOLOGY
- Iron Metabolism in Cancer
- (2018) Yafang Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Low Hematocrit Is a Strong Predictor of Poor Prognosis in Lung Cancer Patients
- (2018) Xin Zhang et al. Biomed Research International
- Preoperative prognostic nutritional index is a powerful predictor of prognosis in patients with stage III ovarian cancer
- (2017) Weiwei Zhang et al. Scientific Reports
- Pretreatment Hematocrit Is Superior to Hemoglobin as a Prognostic Factor for Triple Negative Breast Cancer
- (2016) Bo Chen et al. PLoS One
- An important role of the hepcidin–ferroportin signaling in affecting tumor growth and metastasis
- (2015) Wenli Guo et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- The Prognostic Impact of Duration of Anemia During Chemotherapy in Advanced Epithelial Ovarian Cancer
- (2011) J. H. Kim et al. ONCOLOGIST
- Anemia in cancer
- (2010) M. Dicato et al. ANNALS OF ONCOLOGY
- Role of secondary cytoreductive surgery in ovarian cancer relapse: Who will benefit? A systematic analysis of 240 consecutive patients
- (2010) Jalid Sehouli et al. JOURNAL OF SURGICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started